Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cervical Cancer, January 2024

Free Subscription


Abstracts

Retrieve all available abstracts of the following 326 articles:
HTML format


 

Single Articles

  1. RATHOD S, Potdar J, Gupta A, Sethi N, et al
    Empowering Women's Health: Insights Into HPV Vaccination and the Prevention of Invasive Cervical Cancer.
    Cureus. 2023;15:e49523.
    PubMed    
    Abstract available

  2. FU B, Fang L, Wang R, Zhang X, et al
    Inhibition of Wnt/beta-catenin signaling by monensin in cervical cancer.
    Korean J Physiol Pharmacol. 2024;28:21-30.
    PubMed    
    Abstract available

  3. XU Y, Lai H, Pan S, Pan L, et al
    Selenium promotes immunogenic radiotherapy against cervical cancer metastasis through evoking P53 activation.
    Biomaterials. 2023;305:122452.
    PubMed    
    Abstract available

  4. RUAN X
    Chinese Expert Consensus on ovarian function and fertility preservation of cervical cancer in pregnancy (2023).
    Front Endocrinol (Lausanne). 2023;14:1280631.
    PubMed    
    Abstract available

  5. SHEN T, Zhao J, Li W, Wang X, et al
    Hypertension and hyperglycaemia are positively correlated with local invasion of early cervical cancer.
    Front Endocrinol (Lausanne). 2023;14:1280060.
    PubMed    
    Abstract available

  6. MA X, Zheng J, He K, Wang L, et al
    TGFA expression is associated with poor prognosis and promotes the development of cervical cancer.
    J Cell Mol Med. 2023 Dec 28. doi: 10.1111/jcmm.18086.
    PubMed    
    Abstract available

  7. QIN Q, Yu Z, Tang Y
    Embryonal rhabdomyosarcoma of the uterine cervix.
    Med Ultrason. 2023;25:475-476.
    PubMed    


  8. KANG C, Duo Y, Zheng L, Zhao N, et al
    CAFs-derived exosomes promote the development of cervical cancer by regulating miR-18a-5p-TMEM170B signaling axis.
    Biochem Biophys Res Commun. 2023;694:149403.
    PubMed    
    Abstract available

  9. BENCIC D, Barbaric M, Mornar A, Klaric DA, et al
    Oleuropein in olive leaf, branch, and stem extracts: stability and biological activity in human cervical carcinoma and melanoma cells.
    Acta Pharm. 2023;73:601-616.
    PubMed    
    Abstract available

  10. YANG T, Tian S, Zhao J, Pei M, et al
    LncRNA ABHD11-AS1 activates EGFR signaling to promote cervical cancer progression by preventing FUS-mediated degradation of ABHD11 mRNA.
    Cell Cycle. 2023 Dec 26:1-14. doi: 10.1080/15384101.2023.2297591.
    PubMed    
    Abstract available

  11. LUVIAN-MORALES J, Delgadillo-Gonzalez M, Castro-Eguiluz D, Onate-Ocana LF, et al
    Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Jpn J Clin Oncol. 2023 Dec 23:hyad182. doi: 10.1093.
    PubMed    
    Abstract available

  12. HIBINO Y, Okazawa-Sakai M, Yokoyama T, Fujimoto E, et al
    Abnormal Vaginal Cytology after Total Laparoscopic Hysterectomy in Patients with Cervical Intraepithelial Neoplasia.
    Acta Med Okayama. 2023;77:627-634.
    PubMed    
    Abstract available

  13. SAMARE-NAJAF M, Samareh A, Savardashtaki A, Khajehyar N, et al
    Non-Apoptotic Cell Death Programs in Cervical Cancer with an Emphasis on Ferroptosis.
    Crit Rev Oncol Hematol. 2023 Dec 23:104249.
    PubMed    
    Abstract available

  14. GUAN MM, Rao QX, Huang ML, Wang LJ, et al
    Retracted: Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.
    Med Sci Monit. 2023;29:e943586.
    PubMed    
    Abstract available

  15. DU Y, Ye H, Lin M, Cao L, et al
    KLF14 activates the JNK-signaling pathway to induce S-phase arrest in cervical cancer cells.
    Front Immunol. 2023;14:1267950.
    PubMed    
    Abstract available

  16. ALKHAMIS FH, Alabbas ZAS, Al Mulhim JE, Alabdulmohsin FF, et al
    Prevalence and Predictive Factors of Cervical Cancer Screening in Saudi Arabia: A Nationwide Study.
    Cureus. 2023;15:e49331.
    PubMed    
    Abstract available

  17. BOVO AC, Pedrao PG, Guimaraes YM, Godoy LR, et al
    Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review.
    Rev Bras Ginecol Obstet. 2023;45:e818-e824.
    PubMed    
    Abstract available

  18. ZAGO RA, Camilo-Junior DJ, D'Avilla SCGP, Xavier-Junior JCC, et al
    Underestimated Cervical Cancer among Women over 65 Years Old: Is It Time to Revise the Screening Target Age Group?
    Rev Bras Ginecol Obstet. 2023;45:e790-e795.
    PubMed    
    Abstract available

  19. HUANG L, Liu F, Liu X, Niu L, et al
    Parthenolide inhibits the proliferation and migration of cervical cancer cells via FAK/GSK3beta pathway.
    Cancer Chemother Pharmacol. 2023 Dec 23. doi: 10.1007/s00280-023-04621.
    PubMed    
    Abstract available

  20. SANTOS KVGD, da Silva RLM, Sarmento ACA, Medeiros KS, et al
    Effect of Zingiber Officinale in the Management of Nausea and Vomiting Induced by Treatment With Cisplatin Associated With Radiotherapy: A Randomized Controlled Trial.
    Integr Cancer Ther. 2023;22:15347354231220608.
    PubMed    
    Abstract available

  21. GAMEIRO SF, Salnikov MY, Zeng PYF, Barrett JW, et al
    HPV16 Intratypic Variants in Head and Neck Cancers: A North American Perspective.
    Viruses. 2023;15:2411.
    PubMed    
    Abstract available

  22. LOZAR T, Wang W, Gavrielatou N, Christensen L, et al
    Emerging Prognostic and Predictive Significance of Stress Keratin 17 in HPV-Associated and Non HPV-Associated Human Cancers: A Scoping Review.
    Viruses. 2023;15:2320.
    PubMed    
    Abstract available

  23. WU PJ, Tsai SC, Huang JY, Lee MS, et al
    From Infection to Malignancy: Tracing the Impact of Human Papillomavirus on Uterine Endometrial Cancer in a Nationwide Population-Based Cohort Study.
    Viruses. 2023;15:2314.
    PubMed    
    Abstract available

  24. CAKIR MO, Bilge U, Ghanbari A, Ashrafi GH, et al
    Regulatory Effect of Ficus carica Latex on Cell Cycle Progression in Human Papillomavirus-Positive Cervical Cancer Cell Lines: Insights from Gene Expression Analysis.
    Pharmaceuticals (Basel). 2023;16:1723.
    PubMed    
    Abstract available

  25. CHOOWONGKOMON K, Choengpanya K, Pientong C, Ekalaksananan T, et al
    The Inhibitory Effect of Kerra(TM), KS(TM), and Minoza(TM) on Human Papillomavirus Infection and Cervical Cancer.
    Medicina (Kaunas). 2023;59:2169.
    PubMed    
    Abstract available

  26. DICU-ANDREESCU IG, Marincas MA, Prunoiu VM, Dicu-Andreescu I, et al
    The Impact of Patient Characteristics, Risk Factors, and Surgical Intervention on Survival in a Cohort of Patients Undergoing Neoadjuvant Treatment for Cervical Cancer.
    Medicina (Kaunas). 2023;59:2147.
    PubMed    
    Abstract available

  27. CHOI Y, Ando Y, Lee D, Kim NY, et al
    Profiling of Lymphovascular Space Invasion in Cervical Cancer Revealed PI3K/Akt Signaling Pathway Overactivation and Heterogenic Tumor-Immune Microenvironments.
    Life (Basel). 2023;13:2342.
    PubMed    
    Abstract available

  28. KOURI MA, Spyratou E, Kalkou ME, Patatoukas G, et al
    Nanoparticle-Mediated Radiotherapy: Unraveling Dose Enhancement and Apoptotic Responses in Cancer and Normal Cell Lines.
    Biomolecules. 2023;13:1720.
    PubMed    
    Abstract available

  29. DI DONNA MC, Cucinella G, Giallombardo V, Sozzi G, et al
    Urinary, Gastrointestinal, and Sexual Dysfunctions after Chemotherapy, Radiotherapy, Radical Surgery or Multimodal Treatment in Women with Locally Advanced Cervical Cancer: A Multicenter Retrospective Study.
    Cancers (Basel). 2023;15:5734.
    PubMed    
    Abstract available

  30. ABD RASHID N, Mohamad Najib NH, Abdul Jalil NA, Teoh SL, et al
    Essential Oils in Cervical Cancer: Narrative Review on Current Insights and Future Prospects.
    Antioxidants (Basel). 2023;12:2109.
    PubMed    
    Abstract available

  31. THE LANCET INFECTIOUS DISEASES
    A blueprint for elimination of cervical cancer.
    Lancet Infect Dis. 2024;24:1.
    PubMed    


  32. RAHANGDALE L, Teodoro N, Chinula L, Brewer NT, et al
    Eliminating cervical cancer as a global public health problem requires equitable action.
    BMJ. 2023;383:2978.
    PubMed    


  33. CORONADO PJ, Gracia M
    Robotic radical hysterectomy after conization for patients with small volume early-stage cervical cancer.
    Best Pract Res Clin Obstet Gynaecol. 2023;92:102434.
    PubMed    
    Abstract available

  34. SON YJ, Nam KH, Shim J
    Factors influencing the supportive care needs of female patients with genital cancer in South Korea.
    Medicine (Baltimore). 2023;102:e36650.
    PubMed    
    Abstract available

  35. LIU X, Hou X, Hu K, Zhang F, et al
    Risk Factors for Nodal Failure in Patients with FIGO IIIC Cervical Cancer Receiving Definitive Image-Guided Radiotherapy.
    Curr Oncol. 2023;30:10385-10395.
    PubMed    
    Abstract available

  36. PURI SUDHIR K, Kagenaar E, Meijer M, Hesselink AT, et al
    Comparing the Costs and Diagnostic Outcomes of Replacing Cytology with the QIAsure DNA Methylation Test as a Triage within HPV Primary Cervical Cancer Screening in The Netherlands.
    Diagnostics (Basel). 2023;13:3612.
    PubMed    
    Abstract available

  37. SEVILLA-SANCHEZ MJ, Montoya-Gomez A, Osorno-Valencia D, Montealegre-Sanchez L, et al
    Exploring the Safety of Pllans-II and Antitumoral Potential of Its Recombinant Isoform in Cervical Cancer Therapy.
    Cells. 2023;12:2812.
    PubMed    
    Abstract available

  38. CUI HX, Lou XL, Xia W, Zhang YS, et al
    [Expression of ProEXC and PRMT5 in cervical adenocarcinoma and their clinical significance].
    Zhonghua Yi Xue Za Zhi. 2023;103:3967-3971.
    PubMed    
    Abstract available

  39. UGURLUER G, Zoto Mustafayev T, Gungor G, Abacioglu U, et al
    Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome.
    Clin Oncol (R Coll Radiol). 2024;36:12-20.
    PubMed    
    Abstract available

  40. KAWANA K, Kobayashi O, Ikeda Y, Yahata H, et al
    Phase I and II randomized clinical trial of an oral therapeutic vaccine targeting human papillomavirus for treatment of cervical intraepithelial neoplasia 2 and 3.
    JNCI Cancer Spectr. 2023;7:pkad101.
    PubMed    
    Abstract available

  41. RATNAM S, Jang D, Alaghehbandan R, Gilbert L, et al
    HPV genotype-specific distribution and attributable risk in cervical intraepithelial neoplasia in a referral population with a history of LSIL.
    Cancer Biomark. 2023;38:433-442.
    PubMed    
    Abstract available

  42. TAGHIZADEH PIRPOSHTEH R, Arefian E, Arashkia A, Mohajel N, et al
    Nona-Arginine Mediated Anti-E6 ShRNA Delivery Suppresses the Growth of Hela Cells in vitro.
    Iran Biomed J. 2023;27:349-56.
    PubMed    
    Abstract available

  43. PENG S, Tu H-F, Cheng M, Hu M-H, et al
    Immune responses, therapeutic anti-tumor effects, and tolerability upon therapeutic HPV16/18 E6/E7 DNA vaccination via needle-free biojector.
    mBio. 2023;14:e0212123.
    PubMed    
    Abstract available

  44. LEE SS, Dinicu A, Arthurs L, Shileds D, et al
    Demographic reporting and language exclusion in gynecologic oncology clinical trials.
    Am J Obstet Gynecol. 2023 Sep 24:S0002-9378(23)00639.
    PubMed    
    Abstract available

  45. GUO Q, Qu L, Zhu J, Li H, et al
    Predicting Lymph Node Metastasis From Primary Cervical Squamous Cell Carcinoma Based on Deep Learning in Histopathologic Images.
    Mod Pathol. 2023;36:100316.
    PubMed    
    Abstract available

  46. DOORBAR J
    The human Papillomavirus twilight zone - Latency, immune control and subclinical infection.
    Tumour Virus Res. 2023;16:200268.
    PubMed    
    Abstract available

  47. STERN PL
    Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?
    Tumour Virus Res. 2023;16:200263.
    PubMed    
    Abstract available

  48. WEARN A, Shepherd L
    Determinants of routine cervical screening participation in underserved women: a qualitative systematic review.
    Psychol Health. 2024;39:145-170.
    PubMed    
    Abstract available

  49. KANNO M, Yunokawa M, Fusegi A, Abe A, et al
    Cerebral infarction caused by Trousseau syndrome associated with cervical cancer.
    J Gynecol Oncol. 2024 Jan 1. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  50. M PARVATH ES, John NO, Sathyamurthy A, Ramireddy JK, et al
    Development and validation of a novel scoring system to predict the risk of uterine perforation during intracavitary brachytherapy for cervical cancer.
    J Gynecol Oncol. 2023 Dec 29. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  51. WANG G, Wang Z, Guo Y, Zhang Y, et al
    Evaluation of PTV margins with daily iterative online adaptive radiotherapy for postoperative treatment of endometrial and cervical cancer: a prospective single-arm phase 2 study.
    Radiat Oncol. 2024;19:2.
    PubMed    
    Abstract available

  52. KOK HP, Herrera TD, Crezee J
    Biological treatment evaluation in thermoradiotherapy: application in cervical cancer patients.
    Strahlenther Onkol. 2024 Jan 4. doi: 10.1007/s00066-023-02185.
    PubMed    
    Abstract available

  53. HUNG TM, Son HX, Bang LVN, Van Duyet L, et al
    Characteristics of cervical cancer caused by the human papillomavirus 18 and its genetic variations in Vietnamese women.
    Infect Genet Evol. 2024 Jan 2:105546. doi: 10.1016/j.meegid.2023.105546.
    PubMed    
    Abstract available

  54. WANG Y, Lou C, Zhao S, Li B, et al
    Preparation of polypeptide-metal complexes-coated Hosenkoside A and its inhibitory effect in cervical cancer.
    Int J Biol Macromol. 2024 Jan 2:129177. doi: 10.1016/j.ijbiomac.2023.129177.
    PubMed    
    Abstract available

  55. HERBST J, Vohl V, Krajina M, Leffers M, et al
    Detection of Multiple HPV Types in Liquid Biopsies of Cervical Neoplasia.
    Clin Chem. 2024;70:285-296.
    PubMed    
    Abstract available

  56. PISANI T, Cenci M
    Prevalence of Multiple High Risk Human Papilloma Virus (HR-HPV) Infections in Cervical Cancer Screening in Lazio Region, Italy.
    Cancer Diagn Progn. 2024;4:42-45.
    PubMed    
    Abstract available

  57. ADDO-LARTEY AA, Bonful HA, Sefenu RS, Abagre TA, et al
    Effectiveness of a culturally tailored text messaging program for promoting cervical cancer screening in accra, Ghana: a quasi-experimental trial.
    BMC Womens Health. 2024;24:22.
    PubMed    
    Abstract available

  58. YAN H, Wang Q, Qiao Y
    Cervical cancer prevention in China: where are we now, and what's next?
    Cancer Biol Med. 2024 Jan 2:j.issn.2095-3941.2023.0432.
    PubMed    


  59. YAO H, Li J, Zhou D, Pan X, et al
    FOXM1 transcriptional regulation of RacGAP1 activates the PI3K/AKT signaling pathway to promote the proliferation, migration, and invasion of cervical cancer cells.
    Int J Clin Oncol. 2024 Jan 3. doi: 10.1007/s10147-023-02452.
    PubMed    
    Abstract available

  60. WANG M, Huang K, Wong MCS, Huang J, et al
    Global Cervical Cancer Incidence by Histological Subtype and Implications for Screening Methods.
    J Epidemiol Glob Health. 2024 Jan 3. doi: 10.1007/s44197-023-00172.
    PubMed    
    Abstract available

  61. LI G, Chen Q, Hong S, Yang X, et al
    CNKSR2 expression is correlated with immune infiltrates in Cervical Cancer as a favorable prognostic factor.
    J Cancer. 2024;15:444-455.
    PubMed    
    Abstract available

  62. YUN Z, Li X, Zhu D, Li L, et al
    A meta-analysis examining the impact of open surgical therapy versus minimally invasive surgery on wound infection in females with cervical cancer.
    Int Wound J. 2024 Jan 2. doi: 10.1111/iwj.14535.
    PubMed    
    Abstract available

  63. WANG S, Zhang Y, Ma X, Feng Y, et al
    Function and mechanism of GBP1 in the development and progression of cervical cancer.
    J Transl Med. 2024;22:11.
    PubMed    
    Abstract available

  64. HUSSEIN K, Kokwaro G, Wafula F, Kassie GM, et al
    Factors influencing the uptake and utilization of cervical cancer screening services among women attending public health centers in Addis Ababa, Ethiopia: mixed methods study.
    BMC Womens Health. 2024;24:3.
    PubMed    
    Abstract available

  65. CHEN X, Lu D, Mu Y, Kong L, et al
    The clinical significance of intraoperative adverse events in laparoscopic radical hysterectomies for early-stage cervical cancer.
    BMC Womens Health. 2024;24:1.
    PubMed    
    Abstract available

  66. LI J, Jin H, Sun Y, Wang C, et al
    Reconnoitering correlation between human papillomavirus infection-induced vaginal microecological abnormality and squamous intraepithelial lesion (SIL) progression.
    BMC Womens Health. 2024;24:5.
    PubMed    
    Abstract available

  67. SONG Y, Xia L, Ju X, Wang W, et al
    Development of a supportive care needs eHealth application for patients with cervical cancer undergoing surgery: a feasibility study.
    BMC Health Serv Res. 2024;24:3.
    PubMed    
    Abstract available

  68. ENDEN MR, Moen K, Igland J, Diaz E, et al
    Trends in cervical cancer screening in Norway 2012-2017: a comparison study of non-immigrant and immigrant women.
    Scand J Public Health. 2024 Jan 2:14034948231217636.
    PubMed    
    Abstract available

  69. KOUSSOURI A, Baraquin A, Desmarets M, Diallo K, et al
    Comparison of high-risk HPV detection by the AmpFire(R) HPV Screening 16/18/HR technique (Atila Biosystems) and the hybrid capture 2 test (Qiagen).
    Mol Biol Rep. 2024;51:52.
    PubMed    
    Abstract available

  70. WU KC, Chen SW, Hsieh TC, Yen KY, et al
    Early prediction of distant metastasis in patients with uterine cervical cancer treated with definitive chemoradiotherapy by deep learning using pretreatment [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001799.
    PubMed    
    Abstract available

  71. ONAL C, Guler OC, Torun N, Reyhan M, et al
    Long-term assessment of clinical parameters and positron emission tomography parameters in predicting recurrence in uterine cervical cancer patients receiving definitive chemoradiotherapy.
    Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001800.
    PubMed    
    Abstract available

  72. JAHAN S, Begum F, Nigar K, Sarkar S, et al
    Primary Tuberculosis of Cervix Which Simulated Endocervical Polyp: A Case Study.
    Mymensingh Med J. 2024;33:307-310.
    PubMed    
    Abstract available

  73. CHOUDHOURY S, Latif T, Dhar S, Sarker K, et al
    Analysis of Socio Demographic Risk Factors of Cervical Intraepithelial Neoplasia at Colposcopic Clinic in Mymensingh Medical College Hospital.
    Mymensingh Med J. 2024;33:62-67.
    PubMed    
    Abstract available

  74. LUTHERA NGOMBE MOUABATA DF, Magloire Boumba AL, Bienvenu Massengo NR, Saturnin Pouki F, et al
    Prevalence of co-infection with human papillomavirus and Chlamydia trachomatis and risk factors associated with cervical cancer in Congolese women.
    Microbes Infect. 2023 Dec 30:105287. doi: 10.1016/j.micinf.2023.105287.
    PubMed    
    Abstract available

  75. XU C, Liu W, Zhao Q, Zhang L, et al
    CT-based radiomics nomogram for overall survival prediction in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Front Oncol. 2023;13:1287121.
    PubMed    
    Abstract available

  76. OU Q, Chen Z, Tang J, Chen M, et al
    [Listeria Balanced Lethal Systems Expressing Cervical Cancer Antigen Genes: Construction and Basic Biological Characteristics].
    Sichuan Da Xue Xue Bao Yi Xue Ban. 2023;54:1159-1166.
    PubMed    
    Abstract available

  77. NICHOLS M, Kesaria A, Spencer HJ, Williams HR, et al
    Opioid Use in Patients With Cervical Cancer at a Tertiary Academic Medical Center.
    Anticancer Res. 2024;44:151-155.
    PubMed    
    Abstract available

  78. D'ORIA O, Bogani G, Cuccu I, D'Auge TG, et al
    Pharmacotherapy for the treatment of recurrent cervical cancer: an update of the literature.
    Expert Opin Pharmacother. 2023 Dec 30:1-11. doi: 10.1080/14656566.2023.2298329.
    PubMed    
    Abstract available

  79. LATHROP E, Chissano M, Tevir G, Chongo Y, et al
    Self-sampling for human papilloma virus DNA as a strategy to increase access to cervical cancer screening: patients' and providers' perspectives on facilitators and barriers to scale.
    Afr J Reprod Health. 2023;27:106-111.
    PubMed    
    Abstract available

  80. KIMONI GB, Martin R, Mukengere DM, de Kerchove C, et al
    Screening and risk factors for cervical cancer among survivors of sexual violence in conflict settings, in Eastern Democratic Republic of Congo.
    Afr J Reprod Health. 2023;27:79-85.
    PubMed    
    Abstract available

  81. YAGI A, Nakagawa S, Ueda Y, Oka E, et al
    Effectiveness of catch-up and routine program of the 9-valent vaccine on cervical cancer risk reduction in Japan.
    Cancer Sci. 2023 Dec 30. doi: 10.1111/cas.16055.
    PubMed    
    Abstract available

  82. FANG M, Zhou Y, Li Z, Li X, et al
    Transcriptional factor CCAAT enhancer binding protein beta inhibits epithelial-mesenchymal transition in cervical cancer via regulating attractin-like 1.
    Cell Mol Biol (Noisy-le-grand). 2023;69:1-7.
    PubMed    
    Abstract available

  83. ILAHI NE, Siddique N, Rashid MI, Noreen M, et al
    Decoding the Genetic and Structural Features of HPV16 E5 Oncogene in Cervical Cancer Isolates from Pakistan: A Pilot Study.
    Iran Biomed J. 2023;27:388-96.
    PubMed    
    Abstract available

  84. CHEN X, Tian J, Zhao C, Wu Y, et al
    Resveratrol, a novel inhibitor of FABP5, inhibits cervical cancer metastasis by suppressing fatty acid transport into nucleus and downstream pathways.
    Br J Pharmacol. 2023 Dec 29. doi: 10.1111/bph.16308.
    PubMed    
    Abstract available

  85. JIANG W, Huang G, Pan S, Chen X, et al
    TRAIL-driven targeting and reversing cervical cancer radioresistance by seleno-nanotherapeutics through regulating cell metabolism.
    Drug Resist Updat. 2023;72:101033.
    PubMed    
    Abstract available

  86. WEN S, Lv X, Li P, Li J, et al
    Analysis of cancer-associated fibroblasts in cervical cancer by single-cell RNA sequencing.
    Aging (Albany NY). 2023;15.
    PubMed    
    Abstract available

  87. LAZNIAK S, Sowinska A, Roszak A, Lianeri M, et al
    Role of rs2366152 single-nucleotide variant located in the long noncoding RNA HOTAIR gene in the cervical cancer susceptibility in a Polish population.
    J Appl Genet. 2023 Dec 29. doi: 10.1007/s13353-023-00822.
    PubMed    
    Abstract available

  88. YASIN YS, Jumaa AH, Jabbar S, Abdulkareem AH, et al
    Effect of Laetrile Vinblastine Combination on the Proliferation of the Hela Cancer Cell Line.
    Asian Pac J Cancer Prev. 2023;24:4329-4337.
    PubMed    
    Abstract available

  89. RAI R, Sehgal R, Singhal S, Suri V, et al
    Cervical Cancer Screening Coverage at Tertiary Care Institutes Across India.
    Asian Pac J Cancer Prev. 2023;24:4269-4275.
    PubMed    
    Abstract available

  90. DAVIES P, Aluloski I, Aluloski D, Dizdarevic Maksumic A, et al
    Update on HPV Vaccination Policies and Practices in 17 Eastern European and Central Asian Countries and Territories.
    Asian Pac J Cancer Prev. 2023;24:4227-4235.
    PubMed    
    Abstract available

  91. TEKKESIN N, Goktas S, Alkis V, Tekkesin E, et al
    Male Human Papillomavirus Infection and Genotyping in Turkey.
    Asian Pac J Cancer Prev. 2023;24:4187-4193.
    PubMed    
    Abstract available

  92. RAYA I, Kartina D, Wijaya RI, Irfandi R, et al
    Novel Complex of Zinc (II) Dichloroethylenediamine: Synthesis, Characterization, In-silico, and In-vitro Evaluation against Cervical Cancer Cells.
    Asian Pac J Cancer Prev. 2023;24:4155-4165.
    PubMed    
    Abstract available

  93. OKONOFUA F, Edouard L, Isikhuemen M
    Human papilloma virus (HPV) vaccine and cervical cancer prevention in Africa.
    Afr J Reprod Health. 2023;27:9-14.
    PubMed    
    Abstract available

  94. KOMATSU H, Ikeda Y, Kawana K, Nagase S, et al
    Impact of COVID-19 on gynecological cancer incidence: a large cohort study in Japan.
    Int J Clin Oncol. 2024;29:72-77.
    PubMed    
    Abstract available

  95. NAKOWONG P, Chatchawal P, Chaibun T, Boonapatcharoen N, et al
    Detection of high-risk HPV 16 genotypes in cervical cancers using isothermal DNA amplification with electrochemical genosensor.
    Talanta. 2024;269:125495.
    PubMed    
    Abstract available

  96. SHARMA S, Chauhan D, Kumar S, Kumar R, et al
    Impact of HPV strains on molecular mechanisms of cervix cancer.
    Microb Pathog. 2024;186:106465.
    PubMed    
    Abstract available

  97. DISIPIO T, Pearse E, Jordan S
    Survivorship research in advanced gynecological cancer: A scoping review of cohort studies.
    Cancer Med. 2023;12:21779-21797.
    PubMed    
    Abstract available

  98. KELLY MK, Katzenellenbogen RA, Fiks AG
    What Health Systems Can Do Now to Improve Human Papillomavirus Vaccination.
    JAMA Pediatr. 2024;178:13-14.
    PubMed    


  99. SUN Y, Zhou X, Lucas E, Chen L, et al
    Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance.
    J Pathol Clin Res. 2024;10:e345.
    PubMed    
    Abstract available

  100. GARG A, Galvin AM, Griner SB, Rosberger Z, et al
    HPV self-sampling among women in the United States: preferences for implementation.
    Cancer Causes Control. 2024;35:167-176.
    PubMed    
    Abstract available

  101. NITKOWSKI J, Fernandez ME, Ridolfi T, Chiao E, et al
    The impact of body mass index and physical disability on home-based anal self-sampling.
    Cancer Causes Control. 2024;35:161-166.
    PubMed    
    Abstract available

  102. LI F, Wang Y, Wen M, Aizezi G, et al
    NPHS2-6 drives cervical squamous cell carcinoma (CSCC) progression via hsa-miR-1323/SMC1B axis to activate PI3K-Akt pathway.
    Clin Transl Oncol. 2024;26:245-259.
    PubMed    
    Abstract available

  103. GOYAL A, Booth CN, Souers RJ, Tabbara SO, et al
    Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program.
    Arch Pathol Lab Med. 2024;148:48-54.
    PubMed    
    Abstract available

  104. CHIU HC, Lau CH, Tan SJ, Huang SC, et al
    Successful pregnancy with in vitro fertilization after vaginal radical trachelectomy and pelvic lymphadenectomy in stage IB1 cervical cancer.
    Taiwan J Obstet Gynecol. 2024;63:95-97.
    PubMed    
    Abstract available

  105. KOBAYASHI O, Taguchi A, Nakajima T, Ikeda Y, et al
    Immunotherapy that leverages HPV-specific immune responses for precancer lesions of cervical cancer.
    Taiwan J Obstet Gynecol. 2024;63:22-28.
    PubMed    
    Abstract available

  106. WANG Y, Lyu Y, Che X, Li J, et al
    Can surgery boost the survival benefit of chemoradiotherapy in T1b1-T2a1 stage cervical cancer with lymph node metastasis? A population-based study.
    J Gynecol Oncol. 2023 Dec 29. doi: 10.3802/jgo.2024.
    PubMed    
    Abstract available

  107. JEONG S, Yu H, Park SH, Woo D, et al
    Comparing deep learning and handcrafted radiomics to predict chemoradiotherapy response for locally advanced cervical cancer using pretreatment MRI.
    Sci Rep. 2024;14:1180.
    PubMed    
    Abstract available

  108. ANJAM MAJOUMERD A, Hosseini S, Hosseini SMH, Roshandel G, et al
    Epidemiology of cervical cancer in Iran in 2016: A nationwide study of incidence and regional variation.
    Cancer Rep (Hoboken). 2024 Jan 12:e1973. doi: 10.1002/cnr2.1973.
    PubMed    
    Abstract available

  109. ZHANG Y, Wang G, Chang Y, Wang Z, et al
    Prospects for daily online adaptive radiotherapy for cervical cancer: Auto-contouring evaluation and dosimetric outcomes.
    Radiat Oncol. 2024;19:6.
    PubMed    
    Abstract available

  110. YAO Y, Yan Z, Li C, Zhang S, et al
    Association of HLA class I and II genes with cervical cancer susceptibility in a Han Chinese population.
    HLA. 2024;103:e15340.
    PubMed    
    Abstract available

  111. DAVIDOVIC M, Asangbeh SL, Taghavi K, Dhokotera T, et al
    Facility-Based Indicators to Manage and Scale Up Cervical Cancer Prevention and Care Services for Women Living With HIV in Sub-Saharan Africa: a Three-Round Online Delphi Consensus Method.
    J Acquir Immune Defic Syndr. 2024;95:170-178.
    PubMed    
    Abstract available

  112. MEI X, Xiong J, Liu J, Huang A, et al
    DHCR7 promotes lymph node metastasis in cervical cancer through cholesterol reprogramming-mediated activation of the KANK4/PI3K/AKT axis and VEGF-C secretion.
    Cancer Lett. 2024 Jan 9:216609. doi: 10.1016/j.canlet.2024.216609.
    PubMed    
    Abstract available

  113. HEINERT SW, Ahmed M, Guzman-Baez K, Penugonda A, et al
    Characteristics and Barriers of Emergency Department Patients Overdue for Cancer Screening.
    West J Emerg Med. 2024;25:101-110.
    PubMed    
    Abstract available

  114. ZHANG J, Yu X, Guo Y, Wang D, et al
    HPV16 E6 promoting cervical cancer progression through down-regulation of miR-320a to increase TOP2A expression.
    Cancer Med. 2024 Jan 11. doi: 10.1002/cam4.6875.
    PubMed    
    Abstract available

  115. DHANDE B, Khandeparkar SGS, Gogate BP, Joshi AR, et al
    Immunohistopathological Study of Papillary Squamotransitional Carcinoma of Uterine Cervix.
    Gulf J Oncolog. 2024;1:16-24.
    PubMed    
    Abstract available

  116. ACOSTA LH, Pino MTL, Rocca MV, Cabilla JP, et al
    Soluble guanylyl cyclase beta1 subunit targets epithelial-to-mesenchymal transition and downregulates Akt pathway in human endometrial and cervical cancer cells.
    Heliyon. 2023;10:e23927.
    PubMed    
    Abstract available

  117. HIGGASON N, Nguyen L, Le YC, Juliet Ezeigwe O, et al
    Facilitators to cervical cancer screening in a minority, urban, underserved population.
    Gynecol Oncol Rep. 2023;51:101315.
    PubMed    
    Abstract available

  118. CHEN H, Zhao X, Hu S, You T, et al
    Estimation of economic burden throughout course of cervical squamous intraepithelial lesion and cervical cancer in China: A nationwide multicenter cross-sectional study.
    Chin J Cancer Res. 2023;35:675-685.
    PubMed    
    Abstract available

  119. SONG B, Choi SY
    Factors influencing the intention to engage in cervical cancer preventive behavior in human papillomavirus-infected women: a cross-sectional survey.
    Korean J Women Health Nurs. 2023;29:317-327.
    PubMed    
    Abstract available

  120. ALIMUJIANG Y, Maimaiti A, Ablise M, Yang Z, et al
    Design, Synthesis, and In vitro Anti-cervical Cancer Activity of a Novel MDM2-p53 Inhibitor Based on a Chalcone Scaffold.
    Anticancer Agents Med Chem. 2024.
    PubMed    
    Abstract available

  121. NI BQ, Pan MM, He LX, Li T, et al
    Zimberelimab combined with systemic therapy extended tumor control in post-radiotherapy cervical cancer with brain metastases: A case report.
    J Obstet Gynaecol Res. 2024 Jan 10. doi: 10.1111/jog.15887.
    PubMed    
    Abstract available

  122. CHO O
    Post-Radiotherapy Exosomal Non-Coding RNA and Hemograms for Early Death Prediction in Patients with Cervical Cancer.
    Int J Mol Sci. 2023;25:126.
    PubMed    
    Abstract available

  123. MARGIOULA-SIARKOU C, Almperis A, Gullo G, Almperi EA, et al
    Sentinel Lymph Node Staging in Early-Stage Cervical Cancer: A Comprehensive Review.
    J Clin Med. 2023;13:27.
    PubMed    
    Abstract available

  124. BRAMMALL BR, Garad RM, Teede HJ, Harrison CL, et al
    Evaluating Preconception Health and Behaviour Change in Australian Women Planning a Pregnancy: The OptimalMe Program, a Digital Healthy Lifestyle Intervention with Remotely Delivered Coaching.
    Nutrients. 2024;16:155.
    PubMed    
    Abstract available

  125. VAN KOL K, Ebisch R, Beugeling M, Cnossen J, et al
    Comparing Methods to Determine Complete Response to Chemoradiation in Patients with Locally Advanced Cervical Cancer.
    Cancers (Basel). 2023;16:198.
    PubMed    
    Abstract available

  126. NADILE M, Kornel A, Sze NSK, Tsiani E, et al
    A Comprehensive Review of Genistein's Effects in Preclinical Models of Cervical Cancer.
    Cancers (Basel). 2023;16:35.
    PubMed    
    Abstract available

  127. YANG H, Xu Y, Dong M, Zhang Y, et al
    Automated Prediction of Neoadjuvant Chemoradiotherapy Response in Locally Advanced Cervical Cancer Using Hybrid Model-Based MRI Radiomics.
    Diagnostics (Basel). 2023;14:5.
    PubMed    
    Abstract available

  128. GUO F, Lu R, Kong W, Anwar M, et al
    DNA mismatch repair system regulates the expression of PD-L1 through DNMTs in cervical cancer.
    Cancer Cell Int. 2024;24:25.
    PubMed    
    Abstract available

  129. KANG J, Jiang J, Xiang X, Zhang Y, et al
    Identification of a new gene signature for prognostic evaluation in cervical cancer: based on cuproptosis-associated angiogenesis and multi-omics analysis.
    Cancer Cell Int. 2024;24:23.
    PubMed    
    Abstract available

  130. ZHANG Z, Liu J, Zhang Y, Qu F, et al
    T1 mapping as a quantitative imaging biomarker for diagnosing cervical cancer: a comparison with diffusion kurtosis imaging.
    BMC Med Imaging. 2024;24:16.
    PubMed    
    Abstract available

  131. LI J, Cao Y, Liu Y, Yu L, et al
    Multiomics profiling reveals the benefits of gamma-delta (gammadelta) T lymphocytes for improving the tumor microenvironment, immunotherapy efficacy and prognosis in cervical cancer.
    J Immunother Cancer. 2024;12:e008355.
    PubMed    
    Abstract available

  132. ZHANG Q, Wang Z, Tang H, Zhang B, et al
    Serum CYFRA21-1 and SCC-Ag levels in women during pregnancy and their diagnostic value for cervical cancer.
    Cancer Treat Res Commun. 2023;38:100786.
    PubMed    
    Abstract available

  133. WANG B, Mao Z, Ye J, Jiao X, et al
    Glycolysis Induced by METTL14 Is Essential for Macrophage Phagocytosis and Phenotype in Cervical Cancer.
    J Immunol. 2024 Jan 10:ji2300339. doi: 10.4049/jimmunol.2300339.
    PubMed    
    Abstract available

  134. JIANG Z, Zhang G, Sun T, Zhang G, et al
    Advantages of IMRT optimization with MCO compared to IMRT optimization without MCO in reducing small bowel high dose index for cervical cancer patients-individualized treatment options.
    Transl Cancer Res. 2023;12:3255-3265.
    PubMed    
    Abstract available

  135. TAN F, Xia R, Zeng L, Xie H, et al
    Value of preoperative controlling nutritional status score in prognosis of patients with high-risk factors for early-stage cervical cancer.
    Pak J Med Sci. 2024;40.
    PubMed    
    Abstract available

  136. WANG X, Ye Z, Li S, Yan Z, et al
    A multicenter study of cervical cancer using quantitative diffusion-weighted imaging.
    Acta Radiol. 2024 Jan 9:2841851231222360. doi: 10.1177/02841851231222360.
    PubMed    
    Abstract available

  137. PASSARELLI A, Pisano C, Coppola E, Ventriglia J, et al
    Complete and early response to cemiplimab associated to severe immune toxicity in advanced cervical cancer: a case report.
    Front Immunol. 2023;14:1303893.
    PubMed    
    Abstract available

  138. WANG S, Liu S, Tan S, Yin J, et al
    Characteristics of human papillomavirus prevalence and infection patterns among women aged 25-64 according to age groups and cytology results in Ordos City, China.
    Virol J. 2024;21:12.
    PubMed    
    Abstract available

  139. ZHAI C, Jin X, You L, Yan N, et al
    Hemophagocytic lymphohistiocytosis following pembrolizumab and bevacizumab combination therapy for cervical cancer: a case report and systematic review.
    BMC Geriatr. 2024;24:32.
    PubMed    
    Abstract available

  140. SHARIATI-SARCHESHME M, Mahdizdeh M, Tehrani H, Jamali J, et al
    Women's perception of barriers and facilitators of cervical cancer Pap smear screening: a qualitative study.
    BMJ Open. 2024;14:e072954.
    PubMed    
    Abstract available

  141. KASSA RN, Shifti DM, Alemu K, Omigbodun AO, et al
    Integration of cervical cancer screening into healthcare facilities in low- and middle-income countries: a scoping review protocol.
    BMJ Open. 2024;14:e078466.
    PubMed    
    Abstract available

  142. WASIHUN GA, Addise M, Nega A, Kifle A, et al
    Gap analysis of service quality and associated factors at the oncology center of Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia, 2022: a cross-sectional study.
    BMJ Open. 2024;14:e078239.
    PubMed    
    Abstract available

  143. HONDA R, Nakao Y, Masuda Y, Ohshima K, et al
    Isolated Massive Metastatic Tumor of the Right Ventricle and Pulmonary Artery With Disseminated Intravascular Coagulation in the Distant Period of Cervical Cancer.
    Circ J. 2024 Jan 6. doi: 10.1253/circj.CJ-23-0844.
    PubMed    


  144. VURAL TOPUZ O, Bagbudar S
    Cervical Cancer Metastasis to the Stomach Masquerading as Primary Gastric Cancer: A Case Report of a Rare Metastasis Detected via 18F-FDG PET/CT.
    Nuklearmedizin. 2024 Jan 8. doi: 10.1055/a-2224-9673.
    PubMed    


  145. ZHI S, Gu W, Miao R, Zhang L, et al
    Associations between dyadic communication and dyadic coping of patients with cervical cancer and their spouses: a study utilizing the actor-partner interdependence model.
    Support Care Cancer. 2024;32:90.
    PubMed    
    Abstract available

  146. FU B, Wei L, Wang C, Xiong B, et al
    Nomograms combining computed tomography-based body composition changes with clinical prognostic factors to predict survival in locally advanced cervical cancer patients.
    J Xray Sci Technol. 2024 Jan 5. doi: 10.3233/XST-230212.
    PubMed    
    Abstract available

  147. FAN L, Ma L, Ling R, Guo X, et al
    Clinical value of conventional magnetic resonance imaging combined with diffusion-weighted imaging in predicting pelvic lymph node metastasis of cervical cancer.
    Front Oncol. 2023;13:1267598.
    PubMed    
    Abstract available

  148. WELP AM, Crawford M, O'Brien R, Sullivan SA, et al
    Presence of low volume metastases does not alter management in node-negative, early-stage cervical cancer patients who underwent postoperative adjuvant therapy: A retrospective cohort study.
    Gynecol Oncol Rep. 2023;51:101320.
    PubMed    
    Abstract available

  149. LI X, Zhang Y, Wu H, Li S, et al
    A case of neoadjuvant chemotherapy in pregnancy with cervical cancer (IB3).
    Cancer Treat Res Commun. 2023;38:100749.
    PubMed    
    Abstract available

  150. MWANGI GF, Niyonzima N, Atwine R, Tusubira D, et al
    Dyslipidemia: prevalence and association with precancerous and cancerous lesions of the cervix; a pilot study.
    Lipids Health Dis. 2024;23:3.
    PubMed    
    Abstract available

  151. CHEN XJ, Guo CH, Wang ZC, Yang Y, et al
    Hypoxia-induced ZEB1 promotes cervical cancer immune evasion by strengthening the CD47-SIRPalpha axis.
    Cell Commun Signal. 2024;22:15.
    PubMed    
    Abstract available

  152. DOVER L, Dulaney C
    Neoadjuvant Chemotherapy and Surgery for Cervical Cancer, Timing of Surgery for Esophageal Cancer, Endometrial Cancer Molecular Classification, Vestibular Schwannoma, and Breast Boost Techniques.
    Pract Radiat Oncol. 2024;14:1-5.
    PubMed    


  153. ZHANG Z, Yang Y, Zhang L, Wu Y, et al
    Relationship between Cervicovaginal Microecological Changes and HPV16/18 Infection and Cervical Cancer in Women of Childbearing Age.
    Ann Clin Lab Sci. 2023;53:825-834.
    PubMed    
    Abstract available

  154. SUI H, Shi C, Yan Z, Chen J, et al
    LRRC75A-AS1 drives the epithelial-mesenchymal transition in cervical cancer by binding IGF2BP1 and inhibiting SYVN1-mediated NLRP3 ubiquitination.
    Mol Cancer Res. 2024 Jan 5. doi: 10.1158/1541-7786.MCR-23-0478.
    PubMed    
    Abstract available

  155. SUI X, Xi X
    MCT1 gene silencing enhances the immune effect of dendritic cells on cervical cancer cells.
    Adv Clin Exp Med. 2024 Jan 5. doi: 10.17219/acem/171446.
    PubMed    
    Abstract available

  156. GE WS, Geng W, Shen Y, Bao L, et al
    [The screening of HPV-independent adenocarcinoma in situ of the uterine cervix by cell block: report of a case].
    Zhonghua Bing Li Xue Za Zhi. 2024;53:98-100.
    PubMed    


  157. ZHENG L, Zheng L, Chen S, Liu W, et al
    Human papillomavirus prevalence and genotype distribution in Liaocheng men between 2016 and 2022.
    J Med Virol. 2024;96:e29360.
    PubMed    
    Abstract available

  158. DAI L, Wilson LG, Nakagawa M, Qin Z, et al
    Coinfections with additional oncoviruses in HPV+ individuals: Status, function and potential clinical implications.
    J Med Virol. 2024;96:e29363.
    PubMed    
    Abstract available

  159. RAJKHOWA P, Pundir P, Dsouza SM, Patil DS, et al
    Factors influencing HPV vaccine implementation in South Asia: a scoping review protocol.
    Syst Rev. 2024;13:14.
    PubMed    
    Abstract available

  160. MIYAMA Y, Kato T, Sato M, Yabuno A, et al
    Cervical lymphoepithelioma-like carcinoma with deficient mismatch repair and loss of SMARCA4/BRG1: a case report and five related cases.
    Diagn Pathol. 2024;19:6.
    PubMed    
    Abstract available

  161. FISHER H, Denford S, Audrey S, Finn A, et al
    Information needs of ethnically diverse, vaccine-hesitant parents during decision-making about the HPV vaccine for their adolescent child: a qualitative study.
    BMC Public Health. 2024;24:91.
    PubMed    
    Abstract available

  162. MOSS JL, Entenman J, Stoltzfus K, Liao J, et al
    Self-sampling tools to increase cancer screening among underserved patients: a pilot randomized controlled trial.
    JNCI Cancer Spectr. 2024;8:pkad103.
    PubMed    
    Abstract available

  163. WEN KY, Dayaratna S, Slamon R, Granda-Cameron C, et al
    Chatbot-interfaced and cognitive-affective barrier-driven messages to improve colposcopy adherence after abnormal Pap test results in underserved urban women: A feasibility pilot study.
    Transl Behav Med. 2024;14:1-12.
    PubMed    
    Abstract available

  164. NA DH, Seo AN, Park SY
    Laparoscopic Salvage Surgery for Infrarenal Para-aortic Lymph Node Recurrence of Rectal Cancer.
    Dis Colon Rectum. 2024;67:e119-e120.
    PubMed    


  165. CHOI W, Shim E
    Evaluating the cost-effectiveness of HPV vaccination for adolescent girls in Japan: A comparison of 2-valent, 4-valent, and 9-valent HPV vaccines with consideration of cross-protection.
    Prev Med. 2024;178:107743.
    PubMed    
    Abstract available

  166. WAITE F, Marlow LAV, Nemec M, Waller J, et al
    The impact of age-relevant and generic infographics on knowledge, attitudes and intention to attend cervical screening: A randomized controlled trial.
    Br J Health Psychol. 2024;29:204-220.
    PubMed    
    Abstract available

  167. SHEN Y, Tang X, Lin S, Jin X, et al
    Automatic dose prediction using deep learning and plan optimization with finite-element control for intensity modulated radiation therapy.
    Med Phys. 2024;51:545-555.
    PubMed    
    Abstract available

  168. CURY-MARTINS J, Giannotti MA, Miyashiro D, Pereira J, et al
    A unique case of a lymphoproliferative disorder affecting the skin and uterine cervix on a male transgender.
    An Bras Dermatol. 2024;99:135-139.
    PubMed    


  169. O'DONNELL N, Waller J, Marlow L, Anderson NC, et al
    "Knowing that I had HPV, I literally just shut down": A qualitative exploration of the psychosocial impact of human papillomavirus (HPV) in women living with mental health conditions.
    Br J Health Psychol. 2024;29:80-94.
    PubMed    
    Abstract available

  170. METZ CK, Skof AS, Henrich W, Sehouli J, et al
    Human papillomavirus prevalence in pregnant women living with human immunodeficiency virus infection: a scoping review of the literature.
    J Perinat Med. 2023;52:1-13.
    PubMed    
    Abstract available

  171. CHEBLI P, Strayhorn SM, Hanneke R, Muramatsu N, et al
    A Scoping Review of Cancer Interventions with Arab Americans.
    J Immigr Minor Health. 2024;26:200-226.
    PubMed    
    Abstract available

  172. WALKER L, Burke S, McGeechan GJ
    Understanding perceptions of the public and key stakeholders toward a localised cancer screening promotion campaign.
    Psychol Health Med. 2024;29:317-333.
    PubMed    
    Abstract available

  173. ZHANG L, Li M, Yuan F, Jiang J, et al
    The difference of transcriptome of HPV-infected patients contributes more to the occurrence of cervical cancer than the mutations of E6 and E7 genes in HPV16.
    Medicine (Baltimore). 2024;103:e36822.
    PubMed    
    Abstract available

  174. KAJABWANGU R, Bajunirwe F, Izudi J, Bazira J, et al
    Magnitude and trends in cervical cancer at Mbarara Regional Referral Hospital in South Western Uganda: Retrospective analysis of data from 2017-2022.
    PLOS Glob Public Health. 2024;4:e0002848.
    PubMed    
    Abstract available

  175. CHEN X, Cao R, Liu H, Zhang T, et al
    [Retracted] MicroRNA?15a?5p?targeting oncogene YAP1 inhibits cell viability and induces cell apoptosis in cervical cancer cells.
    Int J Mol Med. 2024;53:24.
    PubMed    
    Abstract available

  176. LUO X, Wei J, Yang FL, Pang XX, et al
    Retraction Note: Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis.
    Cancer Cell Int. 2024;24:39.
    PubMed    


  177. GUPTA S, Kumar P, Das BC
    Challenges and opportunities to making Indian women cervical cancer free.
    Indian J Med Res. 2024 Jan 13. doi: 10.4103/ijmr.ijmr_1052.
    PubMed    


  178. MEZEI A, Trawin J, Payne B, Rawat A, et al
    Acceptability of Integrated Community-Based HIV and Cervical Cancer Screening in Mayuge District, Uganda.
    JCO Glob Oncol. 2024;10:e2200324.
    PubMed    
    Abstract available

  179. DANGAL G, Dhital R, Dwa YP, Poudel S, et al
    Implementation of cervical cancer prevention and screening across five tertiary hospitals in Nepal and its policy implications: A mixed-methods study.
    PLOS Glob Public Health. 2024;4:e0002832.
    PubMed    
    Abstract available

  180. DILLNER J
    Nobel calling Harald zur Hausen.
    J Med Virol. 2024;96:e29414.
    PubMed    


  181. LIU X, Yu B, Gao F, Jing P, et al
    Chemical immune conization of precancerous cervical lesions awakens immune cells and restores normal HPV negative and abnormal proliferation.
    Front Immunol. 2024;14:1259723.
    PubMed    
    Abstract available

  182. KUE J, Tate J, Szalacha LA, Menon U, et al
    A randomized controlled trial of a tailored navigation intervention to promote breast and cervical cancer screening among intergenerational Southeast Asian women.
    Contemp Clin Trials Commun. 2023;37:101248.
    PubMed    
    Abstract available

  183. ABUGHAZALEH S, Tarawneh M, Alzghoul H, Alsakarneh S, et al
    A case report of lung metastasis in a cervical cancer presenting as a consolidation.
    Radiol Case Rep. 2024;19:1144-1148.
    PubMed    
    Abstract available

  184. NYMAN MH, Lillsunde Larsson G, Blomberg K, Schroder A, et al
    Older women's perceptions of HPV self-sampling and HPV-sampling performed by a midwife - a phenomenographic study.
    BMC Public Health. 2024;24:211.
    PubMed    
    Abstract available

  185. HARRIS E
    HPV Screening Could Cut Cervical Cancer Deaths by Up to Two-Thirds.
    JAMA. 2024 Jan 17. doi: 10.1001/jama.2023.27430.
    PubMed    


  186. TIAN P, Feng Y, Tao L
    LINC00460 knockdown sensitizes cervical cancer to cisplatin by downregulating TGFBI.
    Chem Biol Drug Des. 2024;103:e14424.
    PubMed    
    Abstract available

  187. SAKURAMACHI M, Murakami N, Nagao A, Kojima K, et al
    Hydrogel spacer injection to the meso-sigmoid to protect the sigmoid colon in cervical cancer brachytherapy: A technical report.
    J Contemp Brachytherapy. 2023;15:465-469.
    PubMed    
    Abstract available

  188. JI L, Zhang W, Hao S, Wang Z, et al
    Clinical efficacy analysis of radioactive (125)I particle implantation for the treatment of pelvic local recurrence of cervical cancer after radiotherapy.
    J Contemp Brachytherapy. 2023;15:432-441.
    PubMed    
    Abstract available

  189. YAP ET, Dumago MP, Jainar CJ, Bojador M, et al
    Clinical outcomes of single application multi-fractionated CT-guided interstitial high-dose-rate brachytherapy for locally advanced cervical cancer: A multi-institution initial experience.
    J Contemp Brachytherapy. 2023;15:399-404.
    PubMed    
    Abstract available

  190. TU Y, Wang J, Chen Y, Chen Y, et al
    Clinical implementation of three-dimensional standardized template-guided brachytherapy for patients with locally advanced cervical cancer.
    J Contemp Brachytherapy. 2023;15:405-413.
    PubMed    
    Abstract available

  191. PARIKH AA, Hanna J, Shah AP
    Acute keratoconjunctivitis associated with tisotumab vedotin-tftv for metastatic cervical cancer.
    Am J Ophthalmol Case Rep. 2023;33:101979.
    PubMed    
    Abstract available

  192. DONG H, Chen S, Liang X, Cai Q, et al
    Vitamin D and Its Receptors in Cervical Cancer.
    J Cancer. 2024;15:926-938.
    PubMed    
    Abstract available

  193. WANG Q, Lin B, Wei H, Wang X, et al
    AQP3 Promotes the Invasion and Metastasis in Cervical Cancer by Regulating NOX4-derived H(2)O(2) Activation of Syk/PI3K/Akt Signaling Axis.
    J Cancer. 2024;15:1124-1137.
    PubMed    
    Abstract available

  194. INTERNATIONAL BR
    Retracted: Ant Colony Optimization-Enabled CNN Deep Learning Technique for Accurate Detection of Cervical Cancer.
    Biomed Res Int. 2024;2024:9878397.
    PubMed    
    Abstract available

  195. WANG J, Li H, Zhang J, Wang H, et al
    Epidemiology and genotypes analysis of human papillomavirus infection in Beijing, China.
    Virol J. 2024;21:19.
    PubMed    
    Abstract available

  196. MAGAJI FA, Mashor MI, Anzaku SA, Hinjari AR, et al
    Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
    BMC Public Health. 2024;24:193.
    PubMed    
    Abstract available

  197. ELSHAMI M, Abukmail H, Thalji M, Al-Slaibi I, et al
    Myths and common misbeliefs about cervical cancer causation among Palestinian women: a national cross-sectional study.
    BMC Public Health. 2024;24:189.
    PubMed    
    Abstract available

  198. KWAK K, Hwang SS
    Predicted Cervical Cancer Prevention: Impact of National HPV Vaccination Program on Young Women in South Korea.
    Cancer Res Treat. 2024 Jan 15. doi: 10.4143/crt.2023.
    PubMed    
    Abstract available

  199. HARPER DM, Bettcher CM, Young AP
    It Is Time to Switch to Primary HPV Screening for Cervical Cancer.
    Am Fam Physician. 2024;109:8-9.
    PubMed    


  200. STRAATHOF R, Meijaard JP, van Vliet-Perez SM, Kolkman-Deurloo IK, et al
    Multibody dynamic modeling of the behavior of flexible instruments used in cervical cancer brachytherapy.
    Med Phys. 2024 Jan 16. doi: 10.1002/mp.16934.
    PubMed    
    Abstract available

  201. ZHOU YY, Chang M, Li CP, Han XL, et al
    Causal effect of age first had sexual intercourse and lifetime number of sexual partners on cervical cancer.
    Heliyon. 2023;10:e23758.
    PubMed    
    Abstract available

  202. YIM VW, Wang Q, Li Y, Qin C, et al
    Between now and later: a mixed methods study of HPV vaccination delay among Chinese caregivers in urban Chengdu, China.
    BMC Public Health. 2024;24:183.
    PubMed    
    Abstract available

  203. DE SANJOSE S, Perkins RB, Campos N, Inturrisi F, et al
    Design of the HPV-automated visual evaluation (PAVE) study: Validating a novel cervical screening strategy.
    Elife. 2024;12:RP91469.
    PubMed    
    Abstract available

  204. JI HZ, Liu B, Ren M, Li S, et al
    The CXCLs-CXCR2 axis modulates the cross-communication between tumor-associated neutrophils and tumor cells in cervical cancer.
    Expert Rev Clin Immunol. 2024 Jan 15. doi: 10.1080/1744666X.2024.2305808.
    PubMed    
    Abstract available

  205. LI S, Wang L, Shi J, Chen Y, et al
    Chromatin accessibility complex subunit 1 enhances tumor growth by regulating the oncogenic transcription of YAP in breast and cervical cancer.
    PeerJ. 2024;12:e16752.
    PubMed    
    Abstract available

  206. MELESE A, Bekele G, Molla E, Banga D, et al
    Utilization of cervical cancer screening service among female health workforces in public health institutions in south east Ethiopia, a cross-sectional study.
    Heliyon. 2023;10:e23086.
    PubMed    
    Abstract available

  207. WANG Q, Qin W, Gao W, Zhao K, et al
    Correlation between vaginal flora and cervical immune function of human papilloma virus-infected patients with cervical cancer.
    Afr Health Sci. 2023;23:179-185.
    PubMed    
    Abstract available

  208. WU J, Chi X, Yang Q, Li J, et al
    Expression of miR-152 in cervical cancer and its influence on cisplatin resistance.
    Afr Health Sci. 2023;23:246-255.
    PubMed    
    Abstract available

  209. LI F, Wang Y, Yan J, Wu H, et al
    Autologous Tumor-Infiltrating Lymphocyte Mono-Therapy Can Rapidly Shrank Tumor in Asian Patient with Stage III/IV Cervical Cancer: Two Cases Report.
    Int J Womens Health. 2024;16:31-39.
    PubMed    
    Abstract available

  210. SINGH N, Chanco M, Wen V, Mishra N, et al
    Synoptic Operative Reporting in Cervical Cancer Surgeries: Experience From a Single Oncology Center.
    Cureus. 2023;15:e50462.
    PubMed    
    Abstract available

  211. LUO L, Qiao F, Zhou K, Tu Q, et al
    Constructed competitive endogenous RNA network and patterns of immune infiltration revealing the prognostic signature for cervical cancer.
    Epigenomics. 2024;16:23-39.
    PubMed    
    Abstract available

  212. SUN H, Zhao X, Wang X, Ma J, et al
    Correlation analysis of risk factors for cervical lymphatic metastasis in papillary thyroid carcinoma.
    Diagn Pathol. 2024;19:13.
    PubMed    
    Abstract available

  213. M AL KINDI R, H Al Sumri H, M Al Muhdhoori T, Al Mamari K, et al
    Knowledge of cervical cancer screening among Omani women attending a university teaching hospital: a cross-sectional study.
    BMC Womens Health. 2024;24:40.
    PubMed    
    Abstract available

  214. CHOI Y, Ibrahim S, Park LP, Bukusi EA, et al
    The impact of text message reminders on cryotherapy uptake among women testing positive for HPV in western Kenya: a prospective cohort study.
    BMC Womens Health. 2024;24:32.
    PubMed    
    Abstract available

  215. QU X, Xu C, Yang W, Li Q, et al
    KLF5 inhibits the migration and invasion in cervical cancer cell lines by regulating SNAI1.
    Cancer Biomark. 2023 Dec 28. doi: 10.3233/CBM-230175.
    PubMed    
    Abstract available

  216. CHANG KL, Chao WR, Lee YJ, Lin YH, et al
    Mutational analysis of PDGFRA oncogene in high-grade neuroendocrine carcinoma of the uterine cervix in twelve Taiwanese women.
    Taiwan J Obstet Gynecol. 2024;63:125-126.
    PubMed    


  217. OOI KM, Saniasiaya J, Kulasegarah J, Ong DL, et al
    Cervical bronchogenic cyst in a toddler.
    BMJ Case Rep. 2024;17:e256699.
    PubMed    
    Abstract available

  218. CHEN J, Pang L, He L, Li T, et al
    Whether specific genetic feature predicted immunotherapy efficacy: A case report.
    Medicine (Baltimore). 2024;103:e36922.
    PubMed    
    Abstract available

  219. PULIDO E, Gonzalez M, Gamboa O, Bonilla J, et al
    Effectiveness of cryotherapy delivered by nurses for treatment of cervical preneoplasic lesions.
    Biomedica. 2023;43.
    PubMed    
    Abstract available

  220. PENG Q, Wang L, Zuo L, Gao S, et al
    HPV E6/E7: insights into their regulatory role and mechanism in signaling pathways in HPV-associated tumor.
    Cancer Gene Ther. 2024;31:9-17.
    PubMed    
    Abstract available

  221. MOSSERI J, Benoit L, Koual M, Nguyen-Xuan HT, et al
    Margin status after loop electrosurgical excision procedure (LEEP) and laser excision in patients with high-grade cervical neoplasia.
    J Gynecol Obstet Hum Reprod. 2024;53:102707.
    PubMed    
    Abstract available

  222. SEINO M, Nagase S, Tokunaga H, Yamagami W, et al
    Japan Society of Gynecologic Oncology 2022 guidelines for uterine cervical neoplasm treatment.
    J Gynecol Oncol. 2024;35:e15.
    PubMed    
    Abstract available

  223. HARADA N, Sakaeyama Y, Fuchinoue Y, Abe M, et al
    Differentiation between Anterior and Posterior Roots Using Compound Muscle Action Potential in Intradural Extramedullary Spinal Tumor Surgery.
    Neurol Med Chir (Tokyo). 2024;64:36-42.
    PubMed    
    Abstract available

  224. LI Y, Jiang L, Yu Z, Jiang C, et al
    SPRi/SERS dual-mode biosensor based on ployA-DNA/ miRNA/AuNPs-enhanced probe sandwich structure for the detection of multiple miRNA biomarkers.
    Spectrochim Acta A Mol Biomol Spectrosc. 2024;308:123664.
    PubMed    
    Abstract available

  225. ZHANG Y, Wu C, Du J, Xiao Z, et al
    Prediction of recurrence risk factors in patients with early-stage cervical cancers by nomogram based on MRI handcrafted radiomics features and deep learning features: a dual-center study.
    Abdom Radiol (NY). 2024;49:258-270.
    PubMed    
    Abstract available

  226. HAYNES D, Hughes KD, Borrero M, Haas M, et al
    Estimating uninsured and underinsured women eligible for Minnesota's Breast Cancer Screening Program.
    Cancer Causes Control. 2024;35:359-366.
    PubMed    
    Abstract available

  227. HANG S, Haruyama R, Uy K, Fujita N, et al
    Feasibility, accuracy and acceptability of self-sampled human papillomavirus testing using careHPV in Cambodia: a cross-sectional study.
    J Gynecol Oncol. 2024;35:e6.
    PubMed    
    Abstract available

  228. GHARBARAN R, Sayibou Z, Atamturktur S, Ofosu-Mensah JJ, et al
    Diminazene aceturate-induced cytotoxicity is associated with the deregulation of cell cycle signaling and downregulation of oncogenes Furin, c-MYC, and FOXM1 in human cervical carcinoma Hela cells.
    J Biochem Mol Toxicol. 2024;38:e23527.
    PubMed    
    Abstract available

  229. HANCIOGLU T, Pekcevik Y, Akdogan AI, Kucuk U, et al
    Imaging Characteristics Predictive of Cervical Extranodal Tumor Extension in Patients With Head and Neck Squamous Cell Carcinoma.
    J Comput Assist Tomogr. 2024;48:129-136.
    PubMed    
    Abstract available

  230. HU T, Li K, He L, Huang F, et al
    Testing for viral DNA integration among HPV-positive women to detect cervical precancer: An observational cohort study.
    BJOG. 2024;131:309-318.
    PubMed    
    Abstract available

  231. FATTORINI C, Rocca BJ, Giusti A, Arganini M, et al
    Mixed mucinous adenocarcinoma/large cell neuroendocrine carcinoma of the uterine cervix: case report and molecular characterization of a rare entity.
    Virchows Arch. 2024;484:141-146.
    PubMed    
    Abstract available

  232. MALVOLTI S, Soble A, Bloem P, LaMontagne DS, et al
    The Global Demand and Supply Balance of the Human Papillomavirus Vaccine: Implications for the Global Strategy for the Elimination of Cervical Cancer.
    Vaccines (Basel). 2023;12:4.
    PubMed    
    Abstract available

  233. VOINEA SC, Bordea CI, Chitoran E, Rotaru V, et al
    Why Is Surgery Still Done after Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer in Romania?
    Cancers (Basel). 2024;16:425.
    PubMed    
    Abstract available

  234. WANG K, Wang J, Jiang P
    High-Dose-Rate Three-Dimensional Image-Guided Adaptive Brachytherapy (3D IGABT) for Locally Advanced Cervical Cancer (LACC): A Narrative Review on Imaging Modality and Clinical Evidence.
    Curr Oncol. 2023;31:50-65.
    PubMed    
    Abstract available

  235. LIN YT, Wang C, He XY, Yao QM, et al
    Comparative cost-effectiveness of first-line pembrolizumab plus chemotherapy vs. chemotherapy alone in persistent, recurrent, or metastatic cervical cancer.
    Front Immunol. 2024;14:1345942.
    PubMed    
    Abstract available

  236. SZAMRETA EA, Mulvihill E, Aguinaga K, Amos K, et al
    Information needs during cancer care: Qualitative research with locally advanced cervical cancer patients in Brazil, China, Germany, & the US.
    Gynecol Oncol Rep. 2023;51:101321.
    PubMed    
    Abstract available

  237. YADAV G, Srinivasan G, Jain A
    Cervical cancer: Novel treatment strategies offer renewed optimism.
    Pathol Res Pract. 2024;254:155136.
    PubMed    
    Abstract available

  238. AHMAD M, Asrar R, Ahmed I, Bule MH, et al
    HPV vaccination: A key strategy for preventing cervical cancer.
    J Infect Public Health. 2024;17:474-475.
    PubMed    


  239. ROLLE LD, Chery MJ, Larson M, Lopez-Pentecost M, et al
    The Effect of Disability and Social Determinants of Health on Breast and Cervical Cancer Screenings During the COVID-19 Pandemic.
    Prev Chronic Dis. 2024;21:E05.
    PubMed    
    Abstract available

  240. WANG Y, Xie Y, Wang X, Yang N, et al
    Tumor cells-derived extracellular vesicles carry circ_0064516 competitively inhibit microRNA-6805-3p and promote cervical cancer angiogenesis and tumor growth.
    Expert Opin Ther Targets. 2024 Jan 25. doi: 10.1080/14728222.2024.2306353.
    PubMed    
    Abstract available

  241. WANG Y, Yang J, Wang Y
    Serum miRNA Combined With Transvaginal Color Doppler Ultrasound Diagnosis Clinical Research on Cervical Cancer.
    J Ultrasound Med. 2024 Jan 25. doi: 10.1002/jum.16413.
    PubMed    
    Abstract available

  242. BEKALU YE, Wudu MA, Workie Gashu A
    Uptake of cervical cancer screening and associated factors among human immune virus positive women attending antiretroviral therapy clinic in public health facilities, Northeast Ethiopia, 2022: A cross-sectional study.
    SAGE Open Med. 2024;12:20503121231225935.
    PubMed    
    Abstract available

  243. MWALWANDA A, Chavura E, Chisale MRO, Mbakaya BC, et al
    Cervical cancer screening among female health workers: Evidence from a secondary health facility in Northern Malawi.
    Prev Med Rep. 2023;37:102581.
    PubMed    
    Abstract available

  244. LI Y, Zhou Z, Qu J, Gong P, et al
    Role of microRNA-4739 in enhancing cisplatin chemosensitivity by negative regulation of RHBDD2 in human cervical cancer cells.
    Cell Mol Biol Lett. 2024;29:20.
    PubMed    
    Abstract available

  245. LOU J, Zhang X, Liu J, Dong L, et al
    The prognostic value of radiological and pathological lymph node status in patients with cervical cancer who underwent neoadjuvant chemotherapy and followed hysterectomy.
    Sci Rep. 2024;14:2045.
    PubMed    
    Abstract available

  246. BUCK DISILVESTRO J, Ulmer KK, Hedges M, Kardonsky K, et al
    Cervical Cancer: Preventable Deaths Among American Indian/Alaska Native Communities.
    Obstet Gynecol Clin North Am. 2024;51:125-141.
    PubMed    
    Abstract available

  247. XU Z, Guo Y, Wang L, Cui J, et al
    HECW1 restrains cervical cancer cell growth by promoting DVL1 ubiquitination and downregulating the activation of Wnt/beta-catenin signaling.
    Exp Cell Res. 2024 Jan 22:113949. doi: 10.1016/j.yexcr.2024.113949.
    PubMed    
    Abstract available

  248. DUJARDIN C, Balcaen T, Vanoost A, Chatelain D, et al
    [Risk factors for high-grade squamous intraepithelial lesions or cervical cancer in chronic inflammatory bowel disease].
    Gynecol Obstet Fertil Senol. 2024 Jan 22:S2468-7189(24)00012.
    PubMed    
    Abstract available

  249. SONG L, Liang X, Zhu M, Su Q, et al
    Knowledge mapping of immunotherapy in cervical carcinoma: a bibliometric analysis (2000-2023).
    Front Immunol. 2024;14:1328103.
    PubMed    
    Abstract available

  250. HE S, Wang A, Wang J, Tang Z, et al
    Human papillomavirus E7 protein induces homologous recombination defects and PARPi sensitivity.
    J Cancer Res Clin Oncol. 2024;150:27.
    PubMed    
    Abstract available

  251. XU M, Chen H, Tan T, Xie K, et al
    Exploring the causal association between rheumatoid arthritis and the risk of cervical cancer: a two-sample Mendelian randomization study.
    Arthritis Res Ther. 2024;26:35.
    PubMed    
    Abstract available

  252. OUH YT, Kim TJ, Ju W, Kim SW, et al
    Development and validation of artificial intelligence-based analysis software to support screening system of cervical intraepithelial neoplasia.
    Sci Rep. 2024;14:1957.
    PubMed    
    Abstract available

  253. NESSA A, Hossain MS, Uddin SMN, Islam MR, et al
    Electronic aggregated data collection on cervical cancer screening in Bangladesh since 2014: what the data tells us?
    BMC Public Health. 2024;24:270.
    PubMed    
    Abstract available

  254. VAN ERP MAJM, Slaats FMA, Emmen JMA, van Hamont D, et al
    Paraneoplastic anti-TIF1-gamma-positive dermatomyositis as expression of cervical squamous cell carcinoma recurrence.
    BMJ Case Rep. 2024;17:e253636.
    PubMed    
    Abstract available

  255. MASEKO T, Tsoka-Gwegweni JM, Ndirangu J, Okello V, et al
    Knowledge and Perceptions of Cervical Cancer Screening in Nhlambeni, Eswatini: Understanding Facilitators and Barriers for Prevention Interventions.
    West Afr J Med. 2023;40:1325-1331.
    PubMed    
    Abstract available

  256. MASEKO T, Dlamini X, Okello V, Tsoka-Gwegweni JM, et al
    Eswatini Women s Knowledge about Cervical Cancer, Data from a Prevention and Awareness Campaign 2021: A Community Based Cross-sectional Campaign.
    West Afr J Med. 2023;40:1311-1316.
    PubMed    
    Abstract available

  257. WANG Y, Jian W, Zhu L, Cai C, et al
    Attention-Gated Deep-Learning-Based Automatic Digitization of Interstitial Needles in High-Dose-Rate Brachytherapy for Cervical Cancer.
    Adv Radiat Oncol. 2023;9:101340.
    PubMed    
    Abstract available

  258. KONSTANTOPOULOS G, Leventakou D, Saltiel DR, Zervoudi E, et al
    HPV16 E6 Oncogene Contributes to Cancer Immune Evasion by Regulating PD-L1 Expression through a miR-143/HIF-1a Pathway.
    Viruses. 2024;16:113.
    PubMed    
    Abstract available

  259. CASTRO JI, Payan-Valero A, Valencia-Llano CH, Insuasty D, et al
    Evaluation of the Antibacterial, Anti-Cervical Cancer Capacity, and Biocompatibility of Different Graphene Oxides.
    Molecules. 2024;29:281.
    PubMed    
    Abstract available

  260. HUANG Y, Zhang D, Yin L, Zhao J, et al
    Modeling the Health Impact and Cost-Effectiveness of a Combined Schoolgirl HPV Vaccination and Cervical Cancer Screening Program in Guangdong Province, China.
    Children (Basel). 2024;11:103.
    PubMed    
    Abstract available

  261. MULATO-BRIONES IB, Rodriguez-Ildefonso IO, Jimenez-Tenorio JA, Cauich-Sanchez PI, et al
    Cultivable Microbiome Approach Applied to Cervical Cancer Exploration.
    Cancers (Basel). 2024;16:314.
    PubMed    
    Abstract available

  262. MANGA SM, Ye Y, Nulah KL, Manjuh F, et al
    Human Papillomavirus Types and Cervical Cancer Screening among Female Sex Workers in Cameroon.
    Cancers (Basel). 2024;16:243.
    PubMed    
    Abstract available

  263. GU L, Hu Y, Wei Y, Hong Z, et al
    Optimising Cervical Cancer Screening During Pregnancy: A Study of Liquid-Based Cytology and HPV DNA Co-Test.
    Epidemiol Infect. 2024 Jan 23:1-22. doi: 10.1017/S095026882400013.
    PubMed    


  264. ZHOU J, Li H, Wu B, Zhu L, et al
    Network pharmacology combined with experimental verification to explore the potential mechanism of naringenin in the treatment of cervical cancer.
    Sci Rep. 2024;14:1860.
    PubMed    
    Abstract available

  265. LIAO H, Barra C, Zhou Z, Peng X, et al
    MARS an improved de novo peptide candidate selection method for non-canonical antigen target discovery in cancer.
    Nat Commun. 2024;15:661.
    PubMed    
    Abstract available

  266. AN JM, Jeong M, Jung J, Yeo SG, et al
    Next-Generation Femtech: Urine-Based Cervical Cancer Diagnosis Using a Fluorescent Biothiol Probe with Controlled Smiles Rearrangement.
    ACS Appl Mater Interfaces. 2024 Jan 22. doi: 10.1021/acsami.3c17050.
    PubMed    
    Abstract available

  267. AO K, Yin M, Lyu X, Xiao Y, et al
    METTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
    Cancer Lett. 2024 Jan 20:216658. doi: 10.1016/j.canlet.2024.216658.
    PubMed    
    Abstract available

  268. GONG H, Zhao L, Liu J
    Protective effect of tretinoin on cervical cancer growth and proliferation through downregulation of pFAK2 expression.
    Environ Toxicol. 2024 Jan 22. doi: 10.1002/tox.24144.
    PubMed    
    Abstract available

  269. BAXTER L, Wright C
    The importance of rhythms for maintaining consent in diagnostic encounters to detect cervical cancer.
    Sociol Health Illn. 2024 Jan 22. doi: 10.1111/1467-9566.13752.
    PubMed    
    Abstract available

  270. P E, S K, Sagayam KM, J A, et al
    An automated cervical cancer diagnosis using genetic algorithm and CANFIS approaches.
    Technol Health Care. 2024 Jan 4. doi: 10.3233/THC-230926.
    PubMed    
    Abstract available

  271. ZHONG S, Guo Q, Chen X, Luo X, et al
    The inhibition of YTHDF3/m(6)A/LRP6 reprograms fatty acid metabolism and suppresses lymph node metastasis in cervical cancer.
    Int J Biol Sci. 2024;20:916-936.
    PubMed    
    Abstract available

  272. DJORDJEVIC S, Boricic K, Radovanovic S, Simic Vukomanovic I, et al
    Demographic and socioeconomic factors associated with cervical cancer screening among women in Serbia.
    Front Public Health. 2024;11:1275354.
    PubMed    
    Abstract available

  273. ZAMUDIO CANAS R, Jaramillo Flores ME, Vallejo Ruiz V, Delgado Macuil RJ, et al
    Detection of Sialic Acid to Differentiate Cervical Cancer Cell Lines Using a Sambucus nigra Lectin Biosensor.
    Biosensors (Basel). 2024;14:34.
    PubMed    
    Abstract available

  274. AL-BADAWI IA, Abu-Zaid A, Alomar O, Alsabban M, et al
    Association between Endometriosis and the Risk of Ovarian, Endometrial, Cervical, and Breast Cancer: A Population-Based Study from the U.S. National Inpatient Sample 2016-2019.
    Curr Oncol. 2024;31:472-481.
    PubMed    
    Abstract available

  275. SALMAN L, Covens A
    Fertility Preservation in Cervical Cancer-Treatment Strategies and Indications.
    Curr Oncol. 2024;31:296-306.
    PubMed    
    Abstract available

  276. PALMER TJ, Kavanagh K, Cuschieri K, Cameron R, et al
    Invasive cervical cancer incidence following bivalent human papillomavirus vaccination: a population-based observational study of age at immunization, dose, and deprivation.
    J Natl Cancer Inst. 2024 Jan 22:djad263. doi: 10.1093.
    PubMed    
    Abstract available

  277. YEN A, Zhong X, Lin MH, Nwachukwu C, et al
    Improved Dosimetry with Daily Online Adaptive Radiotherapy for Cervical Cancer: Waltzing the Pear.
    Clin Oncol (R Coll Radiol). 2024 Jan 17:S0936-6555(24)00021.
    PubMed    
    Abstract available

  278. ZHANG T, Zhou C, Lv M, Yu J, et al
    Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.
    Eur J Pharm Sci. 2024 Jan 18:106706. doi: 10.1016/j.ejps.2024.106706.
    PubMed    
    Abstract available

  279. MADDAH SAFAEI A, Esmati E, Gomar M, Akhavan S, et al
    Hypofractionated versus standard chemoradiotherapy in the definitive treatment of uterine cervix cancer: interim results of a randomized controlled clinical trial.
    J Cancer Res Clin Oncol. 2024;150:20.
    PubMed    
    Abstract available

  280. JOHNSTON CD, Bullman S
    Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance.
    Trends Cancer. 2024 Jan 18:S2405-8033(24)00001.
    PubMed    
    Abstract available

  281. FAY M, Hu M, Hajizadeh M
    Socioeconomic inequalities in cervical cancer mortality in Canada, 1990 and 2019: a trend analysis.
    Public Health. 2024;227:210-218.
    PubMed    
    Abstract available

  282. LI M, Zheng W
    Sigmoid colonic metastasis from a squamous cell carcinoma of the cervix: A rare case report with literature review.
    Medicine (Baltimore). 2024;103:e37001.
    PubMed    
    Abstract available

  283. ZHOU Z, Feng Y, Xie L, Ma S, et al
    Alterations in gut and genital microbiota associated with gynecological diseases: a systematic review and meta-analysis.
    Reprod Biol Endocrinol. 2024;22:13.
    PubMed    
    Abstract available

  284. BABI A, Issa T, Gusmanov A, Akilzhanova A, et al
    Prevalence of high-risk human papillomavirus infection and genotype distribution among Kazakhstani women with abnormal cervical cytology.
    Ann Med. 2024;56:2304649.
    PubMed    
    Abstract available

  285. GUPTA R, Gupta S
    Point-of-care tests for human papillomavirus detection in uterine cervical samples: A review of advances in resource-constrained settings.
    Indian J Med Res. 2023;158.
    PubMed    
    Abstract available

  286. LIU B, Xu Y, Hu B, Song X, et al
    Immune landscape and heterogeneity of cervical squamous cell carcinoma and adenocarcinoma.
    Aging (Albany NY). 2024;16:568-592.
    PubMed    
    Abstract available

  287. MINHAS S, Kashif M, Nisar H, Idrees M, et al
    Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16.
    Exp Biol Med (Maywood). 2023;248:2332-2340.
    PubMed    
    Abstract available

  288. HU Y, Liu L, Wang C, Zhou J, et al
    CRISPR-Cas12a-enhanced mass spectrometric DNA nanomachine for HPV-16 detection in human serum.
    Chem Commun (Camb). 2024;60:976-979.
    PubMed    
    Abstract available

  289. BARQUIN GARCIA A, Palacios-Zambrano S, Lozano Alarcon F, Paumard-Hernandez B, et al
    Impact of the Identification of Nonhuman Genetic Signatures in the Diagnosis and Management of Carcinoma of Unknown Primary.
    J Natl Compr Canc Netw. 2023;22.
    PubMed    
    Abstract available

  290. KAHRAMAN A, Dirilenoglu F
    Assessing the diagnostic value of CAIX and ProEx-C in cervical squamous intraepithelial lesions.
    Pathol Res Pract. 2024;253:155029.
    PubMed    
    Abstract available

  291. ZHAO S, Li Y, Xu J, Shen L, et al
    APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Neurol Res. 2023 Nov 26:1-16. doi: 10.1080/01616412.2023.2287340.
    PubMed    
    Abstract available

  292. WANG H, Wang WH, Wang W, Ma JH, et al
    Folate deficiency promotes cervical squamous carcinoma SiHa cells progression by targeting miR-375/FZD4/beta-catenin signaling.
    J Nutr Biochem. 2024;124:109489.
    PubMed    
    Abstract available

  293. NITKOWSKI J, Giuliano AR, Ridolfi T, Chiao E, et al
    Acceptability of Anal Human Papillomavirus Home Self-Sampling and Clinician Sampling Among Sexual and Gender Minority Individuals in Milwaukee, Wisconsin: The Prevent Anal Cancer Self-Swab Study.
    LGBT Health. 2024;11:47-56.
    PubMed    
    Abstract available

  294. CROCE S, Devouassoux-Shisheboran M, Pautier P, Ray-Coquard I, et al
    [Diagnosis of uterine sarcomas and rare uterine mesenchymal tumours with malignant potential. Guidelines of the French Sarcoma Group and Rare Gynaecological Tumours].
    Bull Cancer. 2024;111:97-116.
    PubMed    
    Abstract available

  295. CELIKKOL O, Gulseren V, Gungorduk K, Ozdemir IA, et al
    Effects of human papillomavirus and LEEP on sexual function.
    Ir J Med Sci. 2024;193:285-288.
    PubMed    
    Abstract available

  296. TALIA KL, McCluggage WG
    Cervical Adenoid Basal Carcinoma With High-grade Squamous Component: True Mixed Carcinoma or Colonization of Adenoid Basal Carcinoma by High-grade Squamous Intraepithelial Lesion?
    Am J Surg Pathol. 2024;48:238-246.
    PubMed    
    Abstract available


  297. New test for detecting cervical adenocarcinoma.
    Cancer. 2024;130:10.
    PubMed    


  298. BYTNAR JA, McGlynn KA, Nealeigh MD, Shriver CD, et al
    Cancer incidence in the US military: An updated analysis.
    Cancer. 2024;130:96-106.
    PubMed    
    Abstract available

  299. OAKNIN A, Ghamande SA, Kasamatsu Y, Gil-Martin M, et al
    Phase 1 trial of first-line bintrafusp alfa in patients with locally advanced or persistent/recurrent/metastatic cervical cancer.
    Clin Cancer Res. 2024 Jan 2. doi: 10.1158/1078-0432.CCR-23-1829.
    PubMed    
    Abstract available

  300. LUKOVIC J, Pintilie M, Han K, Fyles AW, et al
    An immune gene expression risk score for distant metastases after radiotherapy for cervical cancer.
    Clin Cancer Res. 2024 Jan 5. doi: 10.1158/1078-0432.CCR-23-2085.
    PubMed    
    Abstract available

  301. HALLE MK, Bozickovic O, Forsse D, Wagner-Larsen KS, et al
    Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.
    Gynecol Oncol. 2023;181:110-117.
    PubMed    
    Abstract available

  302. RIVES TA, Orellana TJ, Mumford BS, Sukumvanich P, et al
    The role of obesity in treatment planning for early-stage cervical cancer.
    Gynecol Oncol. 2023;181:60-67.
    PubMed    
    Abstract available

  303. TJIOE KC, Miranda-Galvis M, Johnson MS, Agrawal G, et al
    The interaction between social determinants of health and cervical cancer survival: A systematic review.
    Gynecol Oncol. 2023;181:141-154.
    PubMed    
    Abstract available

  304. FRIEDMAN CF, D'Souza A, Bello Roufai D, Tinker AV, et al
    Targeting HER2-mutant metastatic cervical cancer with neratinib: Final results from the phase 2 SUMMIT basket trial.
    Gynecol Oncol. 2024;181:162-169.
    PubMed    
    Abstract available

  305. MANNING-GEIST B, Grace MA, Sonoda Y
    Trachelectomy and fertility-sparing procedures for early-stage cervical cancer: A state of the science review.
    Gynecol Oncol. 2024;181:179-182.
    PubMed    


  306. LEE SS, Gold HT, Kwon SC, Pothuri B, et al
    Guideline concordant care for patients with locally advanced cervical cancer by disaggregated Asian American and Native Hawaiian/Pacific Islander groups: A National Cancer Database Analysis.
    Gynecol Oncol. 2024;182:132-140.
    PubMed    
    Abstract available

  307. CHOUCHANE-MLIK O, Oniga A, Latouche A, Halladjian M, et al
    Systematic assessment of tumor necrosis at baseline in cervical cancer - An independent factor associated with poor outcome.
    Hum Pathol. 2023;143:62-70.
    PubMed    
    Abstract available

  308. LEHTINEN M, Bruni L, Elfstrom M, Gray P, et al
    Scientific approaches toward improving cervical cancer elimination strategies.
    Int J Cancer. 2024 Jan 9. doi: 10.1002/ijc.34839.
    PubMed    
    Abstract available

  309. AMBOREE TL, Damgacioglu H, Sonawane K, Adsul P, et al
    Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county-level income in the United States, 2000-2019.
    Int J Cancer. 2024 Jan 25. doi: 10.1002/ijc.34860.
    PubMed    
    Abstract available

  310. PORTNOY A, Pedersen K, Sy S, Trope A, et al
    Cost-effectiveness of primary human papillomavirus triage approaches among vaccinated women in Norway: A model-based analysis.
    Int J Cancer. 2024;154:1073-1081.
    PubMed    
    Abstract available

  311. TANG X, Zhang X, Ding Y, Zhang Y, et al
    A long-term retrospective analysis of management of cervical cancer during pregnancy.
    Int J Gynaecol Obstet. 2023 Dec 27. doi: 10.1002/ijgo.15314.
    PubMed    
    Abstract available

  312. MARINO-NOYA A, Magallanes-Pelaez N, Puga-Gonzalez N, Conde-Ferreiros M, et al
    Cervical carcinosarcoma, report of some cases and a literature review.
    Int J Gynaecol Obstet. 2024;164:795-796.
    PubMed    


  313. JIA L, Wang L, Zheng J, Lu J, et al
    Ureter metastasis from a primary cervical malignancy 3 years after initial treatment.
    Int J Gynaecol Obstet. 2024;164:793-794.
    PubMed    


  314. SABEENA S, Ravishankar N, Kalpana MM
    Implementation strategies of cervical cancer screening in South Asia: A systematic review.
    Int J Gynaecol Obstet. 2024 Jan 24. doi: 10.1002/ijgo.15366.
    PubMed    
    Abstract available

  315. LAAN J, van Lonkhuijzen L, Hinnen K, Pieters B, et al
    Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer.
    Int J Gynecol Cancer. 2024 Jan 17:ijgc-2023-005024.
    PubMed    
    Abstract available

  316. HUMPHREY P, Dures E, Hoskin P, Cramp F, et al
    Patient experiences of brachytherapy for locally advanced cervical cancer: hearing the patient voice through qualitative interviews.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08253.
    PubMed    
    Abstract available

  317. KASSICK M, Taunk NK
    Pelvic Nodal Recurrence in Uterine Cancer: Novel Management and a Radiation Riddle.
    Int J Radiat Oncol Biol Phys. 2024;118:318.
    PubMed    


  318. OSTRBENK VALENCAK A, Cuschieri K, Connor L, Zore A, et al
    Allplex HPV HR Detection assay fulfils all clinical performance and reproducibility validation requirements for primary cervical cancer screening.
    J Clin Virol. 2024;170:105638.
    PubMed    
    Abstract available

  319. KAIZILEGE GK, Ndaboine E, Chuma C, Mujuni F, et al
    Unraveling cervical cancer screening dilemmas: histopathological insights from VIA and LEEP at bugando medical centre, Mwanza.
    BMC Cancer. 2024;24:66.
    PubMed    
    Abstract available

  320. KUSSIA B, Shewangizaw M, Abebe S, Alemu H, et al
    Health care seeking behaviour towards cervical cancer screening among women aged 30-49 years in Arbaminch town, Southern Ethiopia, 2023.
    BMC Cancer. 2024;24:38.
    PubMed    
    Abstract available

  321. YU JH, Tong CJ, Huang QD, Ye YL, et al
    Long-term outcomes of pelvic exenterations for gynecological malignancies: a single-center retrospective cohort study.
    BMC Cancer. 2024;24:88.
    PubMed    
    Abstract available

  322. PAN XB, Lu Y, Wei YS, Yao DS, et al
    Efficacy of treatment patterns based on concurrent chemoradiotherapy in patients with stage IIB cervical squamous cell carcinoma.
    BMC Cancer. 2024;24:106.
    PubMed    
    Abstract available

  323. ALJREES T
    Improving prediction of cervical cancer using KNN imputer and multi-model ensemble learning.
    PLoS One. 2024;19:e0295632.
    PubMed    
    Abstract available

  324. MUNSHI RM
    Novel ensemble learning approach with SVM-imputed ADASYN features for enhanced cervical cancer prediction.
    PLoS One. 2024;19:e0296107.
    PubMed    
    Abstract available

  325. YU C, Wu X, Zhang S, Zhang L, et al
    Prognostic model for survival in patients with neuroendocrine carcinomas of the cervix: SEER database analysis and a single-center retrospective study.
    PLoS One. 2024;19:e0296446.
    PubMed    
    Abstract available

  326. GUILLAUME D, Waheed DE, Schleiff M, Muralidharan KK, et al
    Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries.
    PLoS One. 2024;19:e0291990.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.


;